PortfoliosLab logo
SPDR S&P Biotech ETF (XBI)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISIN

US78464A8707

CUSIP

78464A870

Inception Date

Feb 6, 2006

Region

North America (U.S.)

Leveraged

1x

Index Tracked

S&P Biotechnology Select Industry Index

Home Page

www.ssga.com

Asset Class

Equity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

XBI has an expense ratio of 0.35%, placing it in the medium range.


Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

SPDR S&P Biotech ETF (XBI) returned -13.85% year-to-date (YTD) and -16.10% over the past 12 months. Over the past 10 years, XBI returned 0.25% annually, underperforming the S&P 500 benchmark at 10.79%.


XBI

YTD

-13.85%

1M

1.36%

6M

-19.98%

1Y

-16.10%

5Y*

-5.39%

10Y*

0.25%

^GSPC (Benchmark)

YTD

0.60%

1M

9.64%

6M

-0.54%

1Y

11.47%

5Y*

15.67%

10Y*

10.79%

*Annualized

Monthly Returns

The table below presents the monthly returns of XBI, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20252.90%-4.27%-8.57%2.28%-6.47%-13.85%
2024-2.08%12.57%-3.59%-10.82%5.33%4.15%6.85%2.22%-2.41%-1.79%2.67%-9.59%1.01%
20237.11%-6.81%-8.01%5.24%4.64%-0.85%1.31%-6.04%-7.80%-9.30%14.03%18.25%7.60%
2022-16.55%-3.85%0.06%-17.86%-6.84%7.98%9.24%3.17%-5.23%3.57%1.79%-0.74%-25.87%
20218.59%-3.19%-8.32%0.72%-6.24%5.70%-8.86%7.64%-5.37%-0.72%-6.84%-3.71%-20.45%
2020-6.30%0.07%-13.16%20.60%10.89%8.12%-2.34%2.27%-0.26%1.20%18.12%5.82%48.33%
201916.52%6.63%1.57%-5.90%-6.76%10.41%-2.31%-6.20%-5.12%7.06%14.73%1.56%32.56%
201810.02%-3.22%-2.85%-0.85%8.84%0.61%0.11%5.09%-4.19%-17.48%3.21%-12.11%-15.28%
20179.65%8.18%-1.21%3.03%-5.22%14.16%1.28%7.24%3.31%-3.38%-0.54%2.06%43.77%
2016-27.99%-5.24%7.98%4.39%7.64%-6.76%14.77%-3.19%10.37%-15.30%11.61%-5.53%-15.45%
20157.07%7.50%5.17%-8.50%15.43%6.09%1.27%-13.06%-15.86%7.04%8.49%-2.68%13.58%
201415.37%8.99%-12.79%-9.65%2.77%16.86%-5.06%10.77%-3.35%9.89%4.91%3.97%44.97%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of XBI is 5, meaning it’s performing worse than 95% of other ETFs on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of XBI is 55
Overall Rank
The Sharpe Ratio Rank of XBI is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of XBI is 55
Sortino Ratio Rank
The Omega Ratio Rank of XBI is 55
Omega Ratio Rank
The Calmar Ratio Rank of XBI is 77
Calmar Ratio Rank
The Martin Ratio Rank of XBI is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

SPDR S&P Biotech ETF Sharpe ratios as of May 16, 2025 (values are recalculated daily):

  • 1-Year: -0.58
  • 5-Year: -0.16
  • 10-Year: 0.01
  • All Time: 0.28

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of SPDR S&P Biotech ETF compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History

SPDR S&P Biotech ETF provided a 0.18% dividend yield over the last twelve months, with an annual payout of $0.14 per share.


0.00%0.20%0.40%0.60%0.80%1.00%$0.00$0.10$0.20$0.30$0.40$0.50$0.60$0.7020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$0.14$0.13$0.02$0.00$0.04$0.28$0.00$0.20$0.20$0.15$0.43$0.67

Dividend yield

0.18%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%1.07%

Monthly Dividends

The table displays the monthly dividend distributions for SPDR S&P Biotech ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.01$0.00$0.00$0.01
2024$0.00$0.00$0.00$0.00$0.00$0.12$0.00$0.00$0.02$0.00$0.00$0.00$0.13
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.01$0.02
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.04$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.04
2020$0.00$0.00$0.00$0.00$0.00$0.02$0.00$0.00$0.09$0.00$0.00$0.18$0.28
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.06$0.00$0.00$0.06$0.00$0.00$0.07$0.00$0.00$0.01$0.20
2017$0.00$0.00$0.02$0.00$0.00$0.11$0.00$0.00$0.04$0.00$0.00$0.04$0.20
2016$0.00$0.00$0.06$0.00$0.00$0.05$0.00$0.00$0.03$0.00$0.00$0.02$0.15
2015$0.00$0.00$0.08$0.00$0.00$0.15$0.00$0.00$0.05$0.00$0.00$0.15$0.43
2014$0.11$0.00$0.00$0.21$0.00$0.00$0.19$0.00$0.00$0.16$0.67

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the SPDR S&P Biotech ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the SPDR S&P Biotech ETF was 63.89%, occurring on May 11, 2022. The portfolio has not yet recovered.

The current SPDR S&P Biotech ETF drawdown is 55.32%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-63.89%Feb 9, 2021317May 11, 2022
-49.25%Jul 20, 2015144Feb 11, 2016484Jan 12, 2018628
-37.59%Aug 15, 2008139Mar 5, 2009533Apr 14, 2011672
-35.26%Jun 21, 2018129Dec 24, 2018346May 11, 2020475
-29.07%Feb 28, 201449May 8, 2014120Oct 28, 2014169

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...